Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Approximately 60 percent of people experience epistaxis, commonly known as nosebleed, at least once in their lifetime. Of those who experience nosebleed, six percent require medical treatment. A study in the September 2013 issue of Otolaryngology-Head and Neck Surgery, explores which nosebleed treatment options demonstrate the best outcomes.
"Although data exist on the efficacy of the different epistaxis management techniques, outcome comparisons between the modalities for both primary management as well as management of cases of recurrence are currently lacking," the authors stated.
The study analyzed various treatment outcomes of adult patients with epistaxis presenting to otolaryngologists at a tertiary care center between 2005 and 2011. The authors observed 147 patients (94 men and 53 women) who underwent cauterization, tamponade or nondissolvable packing, and/or proximal vascular control through embolization or surgical ligation. Treatment outcomes were then compared with the intent to derive an algorithm for optimal nosebleed management.
According to the study, nondissolvable packing demonstrated the highest rate of failure or recurrence (57.4 percent) for initial bleed management. Chemical cautery was significantly more successful in achieving lasting hemostasis for the first bleeding episode. The authors also found that the duration of the nondissolvable pack placement had no significant impact on nosebleed recurrence. Furthermore, among patients who failed initial management, those who next underwent more invasive procedures such as cautery, embolization or surgical ligation experienced better outcomes and shorter inpatient stays.
Because the subgroup analyses were limited in size for some of the treatment groups in this study, the authors urge caution when considering these findings.
Although most cases of nosebleed do not require medical intervention, those patients who do present to a tertiary care otolaryngologist and need medical attention require a systematic, stepwise approach to address their condition. This study demonstrates "good outcomes with initial treatment with chemical cautery and with procedures that achieve directed vascular control in patients who develop epistaxis recurrence."
Otolaryngology–Head and Neck Surgery is the official scientific journal of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF). The study’s authors are Josef Shargorodsky, MD, MPH; Benjamin S. Bleier, MD; Eric H. Holbrook, MD; Jeffrey M. Cohen; Nicolas Busaba, MD; Ralph Metson, MD, and Stacey T. Gray, MD. Published online before print June 13, 2013, doi: 10.1177/0194599813492949 Otolaryngol Head Neck Surg September 2013 vol. 149 no. 3 390-398
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Ear, Nose and Throat category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
American Academy of Otolaryngology - Head and Neck. "Therapeutic algorithm developed for optimal nosebleed management." Medical News Today. MediLexicon, Intl., 28 Aug. 2013. Web.
9 Dec. 2013. <http://www.medicalnewstoday.com/releases/265267>
American Academy of Otolaryngology - Head and Neck. (2013, August 28). "Therapeutic algorithm developed for optimal nosebleed management." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265267.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.